A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
Titel:
A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study
Auteur:
Türeci, O. Sahin, U. Schulze-Bergkamen, H. Zvirbule, Z. Lordick, F. Koeberle, D. Thuss-Patience, P. Ettrich, T. Arnold, D. Bassermann, F. Al-Batran, S.E. Wiechen, K. Dhaene, K. Maurus, D. Gold, M. Huber, C. Krivoshik, A. Arozullah, A. Park, J.W. Schuler, M.